AVNS
Income statement / Annual
Last year (2024), Avanos Medical, Inc.'s total revenue was $687.80 M,
an increase of 2.15% from the previous year.
In 2024, Avanos Medical, Inc.'s net income was -$392.10 M.
See Avanos Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$687.80 M |
$673.30 M |
$820.00 M |
$744.60 M |
$714.80 M |
$697.60 M |
$652.30 M |
$611.60 M |
$1.59 B |
$1.57 B |
| Cost of Revenue |
$306.50 M
|
$293.60 M
|
$370.00 M
|
$380.30 M
|
$341.50 M
|
$295.40 M
|
$261.40 M
|
$274.70 M
|
$1.03 B
|
$1.04 B
|
| Gross Profit |
$381.30 M
|
$379.70 M
|
$450.00 M
|
$364.30 M
|
$373.30 M
|
$402.20 M
|
$390.90 M
|
$336.90 M
|
$557.90 M
|
$531.60 M
|
| Gross Profit Ratio |
0.55
|
0.56
|
0.55
|
0.49
|
0.52
|
0.58
|
0.6
|
0.55
|
0.35
|
0.34
|
| Research and Development Expenses |
$26.20 M
|
$27.20 M
|
$30.60 M
|
$32.30 M
|
$34.90 M
|
$37.70 M
|
$41.80 M
|
$38.20 M
|
$41.10 M
|
$32.30 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$340.40 M
|
$321.70 M
|
$411.10 M
|
$398.50 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$318.50 M
|
$318.10 M
|
$341.90 M
|
$300.30 M
|
$332.60 M
|
$399.10 M
|
$340.40 M
|
$321.70 M
|
$411.10 M
|
$398.50 M
|
| Other Expenses |
$432.80 M
|
$30.20 M
|
$3.50 M
|
$22.80 M
|
$51.90 M
|
$21.10 M
|
$8.20 M
|
$20.10 M
|
$18.30 M
|
$4.50 M
|
| Operating Expenses |
$777.50 M
|
$375.50 M
|
$376.00 M
|
$355.40 M
|
$419.40 M
|
$457.90 M
|
$390.40 M
|
$380.00 M
|
$470.50 M
|
$435.30 M
|
| Cost And Expenses |
$1.08 B
|
$669.10 M
|
$746.00 M
|
$735.70 M
|
$760.90 M
|
$753.30 M
|
$651.80 M
|
$654.70 M
|
$1.50 B
|
$1.48 B
|
| Interest Income |
$5.10 M
|
$2.90 M
|
$1.20 M
|
$200,000.00
|
$1.20 M
|
$6.70 M
|
$7.80 M
|
$2.50 M
|
$600,000.00
|
$300,000.00
|
| Interest Expense |
$12.20 M
|
$15.00 M
|
$10.00 M
|
$3.30 M
|
$15.60 M
|
$15.00 M
|
$26.40 M
|
$31.60 M
|
$32.70 M
|
$33.10 M
|
| Depreciation & Amortization |
$45.50 M
|
$46.10 M
|
$41.10 M
|
$38.30 M
|
$42.90 M
|
$36.90 M
|
$33.50 M
|
$40.00 M
|
$41.00 M
|
$65.40 M
|
| EBITDA |
-$345.60 M |
$50.60 M |
$77.80 M |
$8.90 M |
-$2.00 M |
-$12.10 M |
$65.70 M |
-$600,000.00 |
-$65.50 M |
-$76.50 M |
| EBITDA Ratio |
-0.5
|
0.08
|
0.15
|
0.06
|
-0
|
-0.02
|
0.06
|
0.03
|
0.1
|
0.1
|
| Operating Income Ratio |
-0.58
|
0.01
|
0.09
|
0.01
|
-0.06
|
-0.08
|
0
|
-0.07
|
0.05
|
-0.24
|
| Total Other Income/Expenses Net |
-$7.10 M
|
-$12.10 M
|
-$8.80 M
|
$44.80 M
|
-$14.40 M
|
-$8.30 M
|
-$18.60 M
|
-$29.10 M
|
-$32.10 M
|
-$274.80 M
|
| Income Before Tax |
-$403.30 M
|
-$7.90 M
|
$65.20 M
|
$5.80 M
|
-$60.50 M
|
-$64.00 M
|
-$18.10 M
|
-$72.20 M
|
$55.30 M
|
-$410.50 M
|
| Income Before Tax Ratio |
-0.59
|
-0.01
|
0.08
|
0.01
|
-0.08
|
-0.09
|
-0.03
|
-0.12
|
0.03
|
-0.26
|
| Income Tax Expense |
-$17.00 M
|
$2.00 M
|
$14.70 M
|
$600,000.00
|
-$33.30 M
|
-$18.10 M
|
-$9.60 M
|
-$40.10 M
|
$15.50 M
|
$15.80 M
|
| Net Income |
-$392.10 M
|
-$61.80 M
|
$50.50 M
|
$6.30 M
|
-$27.20 M
|
-$45.90 M
|
$57.50 M
|
$79.30 M
|
$39.80 M
|
-$426.30 M
|
| Net Income Ratio |
-0.57
|
-0.09
|
0.06
|
0.01
|
-0.04
|
-0.07
|
0.09
|
0.13
|
0.02
|
-0.27
|
| EPS |
-8.52 |
-1.33 |
1.08 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
-9.15 |
| EPS Diluted |
-8.52 |
-1.33 |
1.07 |
0.13 |
-0.57 |
-0.96 |
1.22 |
1.69 |
0.85 |
-9.15 |
| Weighted Average Shares Out |
$46.00 M
|
$46.60 M
|
$46.90 M
|
$48.10 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.52 M
|
$46.60 M
|
$46.59 M
|
| Weighted Average Shares Out Diluted |
$46.00 M
|
$46.60 M
|
$47.30 M
|
$48.60 M
|
$47.80 M
|
$47.60 M
|
$47.20 M
|
$46.80 M
|
$47.00 M
|
$46.59 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
